News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neoprobe Corporation (NEOP) Awarded Grant from Qualifying Therapeutic Discovery Project Program


11/3/2010 8:52:08 AM

DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has been awarded a grant of $244,479 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. The Company’s grant is related to the application submitted for its Lymphoseek® project.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES